Huub Gelderblom is a physician-scientist with the HVTN Leadership Operations Center in Seattle. Huub has an MD, MSc and PhD from the University of Amsterdam, and an MPH from New York University. He has extensive experience working on HIV, hepatitis C, trachoma and SARS-CoV-2 in Europe, Africa, and the US. Huub works on the clinical development of broadly neutralizing antibodies for HIV prevention (also known as passive immunization and passive immunoprophylaxis).
Huub Gelderblom, MD, MSc, PhD, MPH
Biography
Position
HVTN (HIV Vaccine Trials Network) / Fred Hutchinson Cancer Center, United States